Compare OMF & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMF | BIO |
|---|---|---|
| Founded | 1920 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 7.2B |
| IPO Year | 2013 | N/A |
| Metric | OMF | BIO |
|---|---|---|
| Price | $54.58 | $284.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $69.17 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.6M | 294.4K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.65% | N/A |
| EPS Growth | ★ 54.72 | N/A |
| EPS | ★ 6.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $71.78 | $2.31 |
| Revenue Next Year | $6.89 | $3.10 |
| P/E Ratio | ★ $8.37 | $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.00 | $211.43 |
| 52 Week High | $71.93 | $343.12 |
| Indicator | OMF | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 33.90 | 50.13 |
| Support Level | $51.93 | $266.71 |
| Resistance Level | $61.14 | $290.01 |
| Average True Range (ATR) | 1.88 | 9.11 |
| MACD | -0.02 | 2.04 |
| Stochastic Oscillator | 18.21 | 75.36 |
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.